Table 1.

Characteristics of KIULARCO Participants by Outcome at Administrative Censoring on November 15, 2015, Ifakara, Tanzania, 2005–2015

	Outcome at Administrative Censoring in November 2015
	Died		Transferred Out		LTFU		In Active Care		Total
Participant Characteristic	No.	% a	No.	% a	No.	% a	No.	% a	No.	% a
Total	646	9	883	12	2,911	39	3,020	40	7,460	100
At Enrollment
Year of enrollment
2005–2007	324	18	212	12	832	46	444	25	1,812	100
2008–2009	202	8	401	17	1,112	47	663	28	2,378	100
2010–2012	71	4	162	10	712	43	704	43	1,649	100
2013–2015	49	3	108	7	255	16	1,209	75	1,621	100
Sex
Male	263	10	306	12	1,102	42	932	36	2,603	100
Female	383	8	571	12	1,809	37	2,087	43	4,850	100
Missing data	0	0	6	86	0	0	1	14	7	100
Age, years
15–24	46	8	59	11	247	45	200	36	552	100
25–34	190	8	290	12	1,049	43	907	37	2,436	100
35–44	236	9	323	12	950	37	1,084	42	2,593	100
≥45	174	9	211	11	665	35	829	44	1,879	100
Marital status
Married/cohabiting	287	8	454	12	1,443	38	1,628	43	3,812	100
Never married	149	11	152	11	639	45	467	33	1,407	100
Separated/divorced	86	7	132	11	455	37	553	45	1,226	100
Widowed/other	68	9	107	14	287	37	316	41	778	100
Missing data	56	24	38	16	87	37	56	24	237	100
HIV status of partner
Positive	49	5	124	13	300	31	492	51	965	100
Negative	35	7	53	11	181	36	232	46	501	100
Unknown	517	10	629	12	2,210	44	1,703	34	5,059	100
Not applicable	23	4	43	8	77	14	405	74	548	100
Missing data	22	6	34	9	143	37	188	49	387	100
Disclosure of HIV status
No	109	6	205	11	855	45	749	39	1,918	100
Yes	282	7	501	12	1,431	35	1,866	46	4,080	100
Missing data	255	17	177	12	625	43	405	28	1,462	100
Referral to clinic as hospital    inpatient
No	527	8	777	12	2,543	39	2,725	41	6,572	100
Yes	29	8	30	9	120	35	163	48	342	100
Missing data	90	16	76	14	248	45	132	24	546	100
Distance of ward of residence   from clinic, km
1	295	10	223	7	1,071	35	1,511	49	3,100	100
2–49	58	5	69	6	384	35	602	54	1,113	100
50–79	88	11	105	14	385	50	195	25	773	100
≥80	82	7	277	23	496	40	373	30	1,228	100
Missing data	123	10	209	17	575	46	339	27	1,246	100
Smoking status
Never/former smoker	477	8	707	12	2,267	38	2,536	42	5,987	100
Current smoker	95	11	110	12	419	47	263	30	887	100
Missing data	74	13	66	11	225	38	221	38	586	100
Pregnant
No	375	8	547	12	1,699	37	1,980	43	4,601	100
Yes	8	3	24	10	110	44	107	43	249	100
Body mass indexb
Underweight (<18.5)	111	11	102	10	386	39	402	40	1,001	100
Normal (18.5–24.9)	142	6	273	11	857	35	1,209	49	2,481	100
Overweight (25.0–29.9)	13	3	40	8	154	33	266	56	473	100
Obese (≥30.0)	4	3	6	5	40	31	78	61	128	100
Missing data	376	11	462	14	1,474	44	1,065	32	3,377	100
WHO HIV clinical stage
1	116	5	286	12	1,033	42	1,041	42	2,476	100
2	102	7	174	12	548	38	628	43	1,452	100
3	182	10	242	13	756	42	636	35	1,816	100
4	169	19	116	13	372	42	221	25	878	100
Missing data	77	9	65	8	202	24	494	59	838	100
CD4 cell count, cells/mm3
<100	119	11	121	11	398	36	456	42	1,094	100
100–199	48	6	104	13	262	33	382	48	796	100
200–349	41	5	97	11	303	35	428	49	869	100
≥350	48	4	119	9	543	43	555	44	1,265	100
Missing data	390	11	442	13	1,405	41	1,199	35	3,436	100
Tuberculosis
No	585	9	804	12	2,708	40	2,728	40	6,825	100
Yes	61	10	79	12	203	32	292	46	635	100
Initiated ART within 30 days   of enrollment
No	451	11	505	12	1,924	45	1,407	33	4,287	100
Yes	195	6	378	12	987	31	1,613	51	3,173	100
At End of Follow-up
Time since ART initiation   during follow-up,   months
Not yet initiated	302	15	274	13	1,260	62	194	10	2,030	100
0.1–5.9	185	15	141	12	555	46	333	27	1,214	100
6.0–11.9	39	6	86	13	277	42	250	38	652	100
≥12.0	120	3	382	11	819	23	2,243	63	3,564	100
No. of gaps in care (periods of   LTFU)
0	448	17	376	14	0	0	1,783	68	2,607	100
1	162	5	368	11	2,064	62	731	22	3,325	100
2	27	3	90	9	568	58	301	31	986	100
≥3	9	2	49	9	279	51	205	38	542	100

Abbreviations: ART, antiretroviral therapy; HIV, human immunodeficiency virus; KIULARCO, Kilombero and Ulanga Antiretroviral Cohort; LTFU, lost to follow-up; WHO, World Health Organization.

^a Row percentage.

^b Weight (kg)/height (m)². Data were missing for pregnant women.